US Stock MarketDetailed Quotes

ELDN Eledon Pharmaceuticals

Watchlist

2.490
-0.050-1.97%

Close Sep 27 16:00 ET

2.460
-0.030-1.20%

Post 20:02 ET

98.74MMarket Cap-943P/E (TTM)

Eledon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

5.44%-7.77M

11.92%-8.74M

-39.06%-39.53M

3.68%-9.13M

-168.02%-12.25M

-32.23%-8.22M

-21.68%-9.92M

1.69%-28.42M

-2.95%-9.48M

35.56%-4.57M

Net income from continuing operations

31.71%-44.91M

-119.37%-23.63M

-32.48%-116.54M

-47.02%-85.84M

537.70%45.83M

-611.15%-65.76M

-9.21%-10.77M

-154.93%-87.97M

-563.00%-58.38M

-6.66%-10.47M

Operating gains losses

--31.27M

--13.34M

--76.21M

----

Depreciation and amortization

3.19%97K

3.26%95K

0.27%374K

1.08%94K

0.00%94K

-1.08%92K

91.28%373K

52.46%93K

111.36%93K

Change In working capital

980.22%3.16M

142.40%265K

-307.64%-4.92M

47.75%-685K

-189.67%-3.25M

-157.17%-359K

-9.46%-625K

1,657.89%2.37M

32.32%-1.31M

173.77%3.62M

-Change in prepaid assets

348.13%1.43M

-118.47%-87K

-398.78%-1.95M

-11.90%-1.6M

-243.38%-1.15M

-11.36%320K

-48.86%471K

131.22%654K

30.00%-1.43M

40,100.00%800K

-Change in payables and accrued expense

406.50%1.79M

144.30%451K

-224.94%-2.6M

380.48%1.01M

-168.86%-2.01M

-262.95%-585K

27.34%-1.02M

-2.89%2.08M

28.83%210K

112.47%2.91M

-Change in other current liabilities

28.72%-67K

-26.92%-99K

1.09%-363K

-3.23%-96K

-4.40%-95K

-2.17%-94K

14.29%-78K

-83.50%-367K

-55.00%-93K

-97.83%-91K

Cash from discontinued investing activities

Operating cash flow

5.44%-7.77M

11.92%-8.74M

-39.06%-39.53M

3.68%-9.13M

-168.02%-12.25M

-32.23%-8.22M

-21.68%-9.92M

1.69%-28.42M

-2.95%-9.48M

35.56%-4.57M

Investing cash flow

Cash flow from continuing investing activities

34.35%-19.91M

9.78M

-45.29M

10.08M

-25.03M

-30.33M

Net investment purchase and sale

34.35%-19.91M

--9.78M

---45.29M

--10.08M

---25.03M

---30.33M

--0

Cash from discontinued investing activities

Investing cash flow

34.35%-19.91M

--9.78M

---45.29M

--10.08M

---25.03M

---30.33M

--0

Financing cash flow

Cash flow from continuing financing activities

45.59%48.07M

33.02M

Net common stock issuance

45.59%48.07M

--1K

--33.02M

--0

--33.02M

--0

Cash from discontinued financing activities

Financing cash flow

45.59%48.07M

--1K

--33.02M

--0

--33.02M

--0

Net cash flow

Beginning cash position

-87.83%5.66M

-91.82%4.61M

-33.51%56.41M

-94.43%3.67M

-41.89%40.95M

-39.38%46.49M

-33.51%56.41M

-25.71%84.83M

-29.94%65.89M

-30.33%70.46M

Current changes in cash

468.08%20.38M

110.51%1.04M

-82.23%-51.8M

109.97%945K

-715.58%-37.28M

10.92%-5.54M

-21.68%-9.92M

3.19%-28.42M

-2.95%-9.48M

35.55%-4.57M

End cash Position

-36.41%26.04M

-87.83%5.66M

-91.82%4.61M

-94.43%3.67M

-41.89%40.95M

-39.38%46.49M

-33.51%56.41M

-29.94%65.89M

Free cash flow

5.44%-7.77M

11.92%-8.74M

-39.06%-39.53M

3.68%-9.13M

-168.02%-12.25M

-32.23%-8.22M

-21.68%-9.92M

1.69%-28.42M

-2.95%-9.48M

35.56%-4.57M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	5.44%-7.77M	11.92%-8.74M	-39.06%-39.53M	3.68%-9.13M	-168.02%-12.25M	-32.23%-8.22M	-21.68%-9.92M	1.69%-28.42M	-2.95%-9.48M	35.56%-4.57M
Net income from continuing operations	31.71%-44.91M	-119.37%-23.63M	-32.48%-116.54M	-47.02%-85.84M	537.70%45.83M	-611.15%-65.76M	-9.21%-10.77M	-154.93%-87.97M	-563.00%-58.38M	-6.66%-10.47M
Operating gains losses	--31.27M	--13.34M	--76.21M	----	----	----	----	----	----	----
Depreciation and amortization	3.19%97K	3.26%95K	0.27%374K	1.08%94K	1.08%94K	0.00%94K	-1.08%92K	91.28%373K	52.46%93K	111.36%93K
Change In working capital	980.22%3.16M	142.40%265K	-307.64%-4.92M	47.75%-685K	-189.67%-3.25M	-157.17%-359K	-9.46%-625K	1,657.89%2.37M	32.32%-1.31M	173.77%3.62M
-Change in prepaid assets	348.13%1.43M	-118.47%-87K	-398.78%-1.95M	-11.90%-1.6M	-243.38%-1.15M	-11.36%320K	-48.86%471K	131.22%654K	30.00%-1.43M	40,100.00%800K
-Change in payables and accrued expense	406.50%1.79M	144.30%451K	-224.94%-2.6M	380.48%1.01M	-168.86%-2.01M	-262.95%-585K	27.34%-1.02M	-2.89%2.08M	28.83%210K	112.47%2.91M
-Change in other current liabilities	28.72%-67K	-26.92%-99K	1.09%-363K	-3.23%-96K	-4.40%-95K	-2.17%-94K	14.29%-78K	-83.50%-367K	-55.00%-93K	-97.83%-91K
Cash from discontinued investing activities
Operating cash flow	5.44%-7.77M	11.92%-8.74M	-39.06%-39.53M	3.68%-9.13M	-168.02%-12.25M	-32.23%-8.22M	-21.68%-9.92M	1.69%-28.42M	-2.95%-9.48M	35.56%-4.57M
Investing cash flow
Cash flow from continuing investing activities	34.35%-19.91M	9.78M	-45.29M	10.08M	-25.03M	-30.33M	0	0	0	0
Net investment purchase and sale	34.35%-19.91M	--9.78M	---45.29M	--10.08M	---25.03M	---30.33M	--0	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	34.35%-19.91M	--9.78M	---45.29M	--10.08M	---25.03M	---30.33M	--0	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	45.59%48.07M	1K	33.02M	0	0	33.02M	0	0	0	0
Net common stock issuance	45.59%48.07M	--1K	--33.02M	--0	--0	--33.02M	--0	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	45.59%48.07M	--1K	--33.02M	--0	--0	--33.02M	--0	--0	--0	--0
Net cash flow
Beginning cash position	-87.83%5.66M	-91.82%4.61M	-33.51%56.41M	-94.43%3.67M	-41.89%40.95M	-39.38%46.49M	-33.51%56.41M	-25.71%84.83M	-29.94%65.89M	-30.33%70.46M
Current changes in cash	468.08%20.38M	110.51%1.04M	-82.23%-51.8M	109.97%945K	-715.58%-37.28M	10.92%-5.54M	-21.68%-9.92M	3.19%-28.42M	-2.95%-9.48M	35.55%-4.57M
End cash Position	-36.41%26.04M	-87.83%5.66M	-91.82%4.61M	-91.82%4.61M	-94.43%3.67M	-41.89%40.95M	-39.38%46.49M	-33.51%56.41M	-33.51%56.41M	-29.94%65.89M
Free cash flow	5.44%-7.77M	11.92%-8.74M	-39.06%-39.53M	3.68%-9.13M	-168.02%-12.25M	-32.23%-8.22M	-21.68%-9.92M	1.69%-28.42M	-2.95%-9.48M	35.56%-4.57M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data